All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial

7d agoen
sciencehealth
Read on clinicaltrials.gov

From the article

Conditions : Central Serous Chorioretinopathy (CSC) Interventions : Drug: Faricimab; Drug: Sham Sponsors : Singapore National Eye Centre; Hoffmann-La Roche Not yet recruiting
Continue reading on clinicaltrials.gov

You might also wanna read

Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells

doi.org·13d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.